PubMed:29049388
Annnotations
LitCoin-entities-OrganismTaxon-PD
| Id | Subject | Object | Predicate | Lexical cue | db_id |
|---|---|---|---|---|---|
| T1 | 13-18 | OrganismTaxon | denotes | mouse | NCBItxid:10090|NCBItxid:10088 |
| T3 | 296-300 | OrganismTaxon | denotes | mice | NCBItxid:10095|NCBItxid:10088 |
| T5 | 332-337 | OrganismTaxon | denotes | mouse | NCBItxid:10090|NCBItxid:10088 |
| T7 | 350-355 | OrganismTaxon | denotes | human | NCBItxid:9606 |
| T8 | 1690-1695 | OrganismTaxon | denotes | mouse | NCBItxid:10090|NCBItxid:10088 |
| T10 | 1761-1766 | OrganismTaxon | denotes | human | NCBItxid:9606 |
| T11 | 1849-1854 | OrganismTaxon | denotes | human | NCBItxid:9606 |
LitCoin-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-72 | Sentence | denotes | An inducible mouse model of podocin-mutation-related nephrotic syndrome. |
| T2 | 73-156 | Sentence | denotes | Mutations in the NPHS2 gene, encoding podocin, cause hereditary nephrotic syndrome. |
| T3 | 157-286 | Sentence | denotes | The most common podocin mutation, R138Q, is associated with early disease onset and rapid progression to end-stage renal disease. |
| T4 | 287-443 | Sentence | denotes | Knock-in mice carrying a R140Q mutation, the mouse analogue of human R138Q, show developmental arrest of podocytes and lethal renal failure at neonatal age. |
| T5 | 444-632 | Sentence | denotes | Here we created a conditional podocin knock-in model named NPHS2 R140Q/-, using a tamoxifen-inducible Cre recombinase, which permits to study the effects of the mutation in postnatal life. |
| T6 | 633-751 | Sentence | denotes | Within the first week of R140Q hemizygosity induction the animals developed proteinuria, which peaked after 4-5 weeks. |
| T7 | 752-856 | Sentence | denotes | Subsequently the animals developed progressive renal failure, with a median survival time of 12 (95% CI: |
| T8 | 857-870 | Sentence | denotes | 11-13) weeks. |
| T9 | 871-994 | Sentence | denotes | Foot process fusion was observed within one week, progressing to severe and global effacement in the course of the disease. |
| T10 | 995-1119 | Sentence | denotes | The number of podocytes per glomerulus gradually diminished to 18% compared to healthy controls 12-16 weeks after induction. |
| T11 | 1120-1223 | Sentence | denotes | The fraction of segmentally sclerosed glomeruli was 25%, 85% and 97% at 2, 4 and 8 weeks, respectively. |
| T12 | 1224-1382 | Sentence | denotes | Severe tubulointerstitial fibrosis was present at later disease stage and was correlated quantitatively with the level of proteinuria at early disease stages. |
| T13 | 1383-1516 | Sentence | denotes | While R140Q podocin mRNA expression was elevated, protein abundance was reduced by more than 50% within one week following induction. |
| T14 | 1517-1646 | Sentence | denotes | Whereas miRNA21 expression persistently increased during the first 4 weeks, miRNA-193a expression peaked 2 weeks after induction. |
| T15 | 1647-1864 | Sentence | denotes | In conclusion, the inducible R140Q-podocin mouse model is an auspicious model of the most common genetic cause of human nephrotic syndrome, with a spontaneous disease course strongly reminiscent of the human disorder. |
| T16 | 1865-2089 | Sentence | denotes | This model constitutes a valuable tool to test the efficacy of novel pharmacological interventions aimed to improve podocyte function and viability and attenuate proteinuria, glomerulosclerosis and progressive renal failure. |
LitCoin-entities
| Id | Subject | Object | Predicate | Lexical cue | db_id |
|---|---|---|---|---|---|
| 13466 | 13-18 | OrganismTaxon | denotes | mouse | NCBITaxon:10090 |
| 13467 | 28-35 | GeneOrGeneProduct | denotes | podocin | NCBIGene:170484 |
| 13468 | 53-71 | DiseaseOrPhenotypicFeature | denotes | nephrotic syndrome | MESH:D009404 |
| 13469 | 90-95 | GeneOrGeneProduct | denotes | NPHS2 | NCBIGene:7827 |
| 13470 | 111-118 | GeneOrGeneProduct | denotes | podocin | NCBIGene:7827 |
| 13471 | 137-155 | DiseaseOrPhenotypicFeature | denotes | nephrotic syndrome | MESH:D009404 |
| 13472 | 173-180 | GeneOrGeneProduct | denotes | podocin | NCBIGene:7827 |
| 13473 | 191-196 | SequenceVariant | denotes | R138Q | DBSNP:rs74315342 |
| 13474 | 272-285 | DiseaseOrPhenotypicFeature | denotes | renal disease | MESH:D007674 |
| 13475 | 296-300 | OrganismTaxon | denotes | mice | NCBITaxon:10090 |
| 13476 | 312-317 | SequenceVariant | denotes | R140Q | p|SUB|R|140|Q |
| 13477 | 332-337 | OrganismTaxon | denotes | mouse | NCBITaxon:10090 |
| 13478 | 350-355 | OrganismTaxon | denotes | human | NCBITaxon:9606 |
| 13479 | 356-361 | SequenceVariant | denotes | R138Q | DBSNP:rs74315342 |
| 13480 | 413-426 | DiseaseOrPhenotypicFeature | denotes | renal failure | MESH:D051437 |
| 13481 | 474-481 | GeneOrGeneProduct | denotes | podocin | NCBIGene:170484 |
| 13482 | 503-508 | GeneOrGeneProduct | denotes | NPHS2 | NCBIGene:170484 |
| 13483 | 509-514 | SequenceVariant | denotes | R140Q | p|SUB|R|140|Q |
| 13484 | 526-535 | ChemicalEntity | denotes | tamoxifen | MESH:D013629 |
| 13485 | 658-663 | SequenceVariant | denotes | R140Q | p|SUB|R|140|Q |
| 13486 | 709-720 | DiseaseOrPhenotypicFeature | denotes | proteinuria | MESH:D011507 |
| 13487 | 799-812 | DiseaseOrPhenotypicFeature | denotes | renal failure | MESH:D051437 |
| 13488 | 1231-1258 | DiseaseOrPhenotypicFeature | denotes | tubulointerstitial fibrosis | MESH:D007674 |
| 13489 | 1346-1357 | DiseaseOrPhenotypicFeature | denotes | proteinuria | MESH:D011507 |
| 13490 | 1389-1394 | SequenceVariant | denotes | R140Q | p|SUB|R|140|Q |
| 13491 | 1395-1402 | GeneOrGeneProduct | denotes | podocin | NCBIGene:170484 |
| 13492 | 1525-1532 | GeneOrGeneProduct | denotes | miRNA21 | NCBIGene:406991 |
| 13493 | 1593-1603 | GeneOrGeneProduct | denotes | miRNA-193a | NCBIGene:406968 |
| 13494 | 1676-1681 | SequenceVariant | denotes | R140Q | p|SUB|R|140|Q |
| 13495 | 1682-1689 | GeneOrGeneProduct | denotes | podocin | NCBIGene:170484 |
| 13496 | 1690-1695 | OrganismTaxon | denotes | mouse | NCBITaxon:10090 |
| 13497 | 1761-1766 | OrganismTaxon | denotes | human | NCBITaxon:9606 |
| 13498 | 1767-1785 | DiseaseOrPhenotypicFeature | denotes | nephrotic syndrome | MESH:D009404 |
| 13499 | 1849-1854 | OrganismTaxon | denotes | human | NCBITaxon:9606 |
| 13500 | 2027-2038 | DiseaseOrPhenotypicFeature | denotes | proteinuria | MESH:D011507 |
| 13501 | 2040-2058 | DiseaseOrPhenotypicFeature | denotes | glomerulosclerosis | MESH:D005921 |
| 13502 | 2075-2088 | DiseaseOrPhenotypicFeature | denotes | renal failure | MESH:D051437 |
LitCoin_Mondo
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T1 | 53-71 | DiseaseOrPhenotypicFeature | denotes | nephrotic syndrome | 0005377 |
| T2 | 137-155 | DiseaseOrPhenotypicFeature | denotes | nephrotic syndrome | 0005377 |
| T3 | 709-720 | DiseaseOrPhenotypicFeature | denotes | proteinuria | 0003634 |
| T4 | 1346-1357 | DiseaseOrPhenotypicFeature | denotes | proteinuria | 0003634 |
| T5 | 1767-1785 | DiseaseOrPhenotypicFeature | denotes | nephrotic syndrome | 0005377 |
| T6 | 2027-2038 | DiseaseOrPhenotypicFeature | denotes | proteinuria | 0003634 |
| T7 | 2040-2058 | DiseaseOrPhenotypicFeature | denotes | glomerulosclerosis | 0000490 |
LitCoin-SeqVar
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 191-196 | SequenceVariant | denotes | R138Q |
| T2 | 312-317 | SequenceVariant | denotes | R140Q |
| T3 | 356-361 | SequenceVariant | denotes | R138Q |
| T4 | 509-514 | SequenceVariant | denotes | R140Q |
| T5 | 658-663 | SequenceVariant | denotes | R140Q |
| T6 | 1389-1394 | SequenceVariant | denotes | R140Q |
| T7 | 1676-1681 | SequenceVariant | denotes | R140Q |
LitCoin-GeneOrGeneProduct-v0
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 3-12 | GeneOrGeneProduct | denotes | inducible |
| T2 | 28-35 | GeneOrGeneProduct | denotes | podocin |
| T3 | 36-44 | GeneOrGeneProduct | denotes | mutation |
| T4 | 63-71 | GeneOrGeneProduct | denotes | syndrome |
| T5 | 73-82 | GeneOrGeneProduct | denotes | Mutations |
| T6 | 90-95 | GeneOrGeneProduct | denotes | NPHS2 |
| T7 | 111-118 | GeneOrGeneProduct | denotes | podocin |
| T8 | 147-155 | GeneOrGeneProduct | denotes | syndrome |
| T9 | 173-180 | GeneOrGeneProduct | denotes | podocin |
| T10 | 181-189 | GeneOrGeneProduct | denotes | mutation |
| T11 | 217-222 | GeneOrGeneProduct | denotes | early |
| T12 | 262-265 | GeneOrGeneProduct | denotes | end |
| T13 | 296-300 | GeneOrGeneProduct | denotes | mice |
| T14 | 318-326 | GeneOrGeneProduct | denotes | mutation |
| T15 | 382-388 | GeneOrGeneProduct | denotes | arrest |
| T16 | 406-412 | GeneOrGeneProduct | denotes | lethal |
| T17 | 452-459 | GeneOrGeneProduct | denotes | created |
| T18 | 474-481 | GeneOrGeneProduct | denotes | podocin |
| T19 | 503-508 | GeneOrGeneProduct | denotes | NPHS2 |
| T20 | 536-545 | GeneOrGeneProduct | denotes | inducible |
| T21 | 550-561 | GeneOrGeneProduct | denotes | recombinase |
| T22 | 605-613 | GeneOrGeneProduct | denotes | mutation |
| T23 | 837-841 | GeneOrGeneProduct | denotes | time |
| T24 | 876-883 | GeneOrGeneProduct | denotes | process |
| T25 | 884-890 | GeneOrGeneProduct | denotes | fusion |
| T26 | 1019-1022 | GeneOrGeneProduct | denotes | per |
| T27 | 1189-1193 | GeneOrGeneProduct | denotes | at 2 |
| T28 | 1195-1200 | GeneOrGeneProduct | denotes | 4 and |
| T29 | 1271-1279 | GeneOrGeneProduct | denotes | at later |
| T30 | 1361-1366 | GeneOrGeneProduct | denotes | early |
| T31 | 1395-1402 | GeneOrGeneProduct | denotes | podocin |
| T32 | 1403-1407 | GeneOrGeneProduct | denotes | mRNA |
| T33 | 1433-1440 | GeneOrGeneProduct | denotes | protein |
| T34 | 1455-1462 | GeneOrGeneProduct | denotes | reduced |
| T35 | 1525-1532 | GeneOrGeneProduct | denotes | miRNA21 |
| T36 | 1544-1556 | GeneOrGeneProduct | denotes | persistently |
| T37 | 1615-1623 | GeneOrGeneProduct | denotes | peaked 2 |
| T38 | 1666-1675 | GeneOrGeneProduct | denotes | inducible |
| T39 | 1682-1689 | GeneOrGeneProduct | denotes | podocin |
| T40 | 1777-1785 | GeneOrGeneProduct | denotes | syndrome |
| T41 | 1907-1911 | GeneOrGeneProduct | denotes | test |
| T42 | 1928-1933 | GeneOrGeneProduct | denotes | novel |
| T43 | 2003-2012 | GeneOrGeneProduct | denotes | viability |
| T44 | 2017-2026 | GeneOrGeneProduct | denotes | attenuate |
LitCoin-GeneOrGeneProduct-v2
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 3-12 | GeneOrGeneProduct | denotes | inducible |
| T2 | 28-35 | GeneOrGeneProduct | denotes | podocin |
| T3 | 63-71 | GeneOrGeneProduct | denotes | syndrome |
| T4 | 90-95 | GeneOrGeneProduct | denotes | NPHS2 |
| T5 | 111-118 | GeneOrGeneProduct | denotes | podocin |
| T6 | 147-155 | GeneOrGeneProduct | denotes | syndrome |
| T7 | 173-180 | GeneOrGeneProduct | denotes | podocin |
| T8 | 217-222 | GeneOrGeneProduct | denotes | early |
| T9 | 382-388 | GeneOrGeneProduct | denotes | arrest |
| T10 | 406-412 | GeneOrGeneProduct | denotes | lethal |
| T11 | 474-481 | GeneOrGeneProduct | denotes | podocin |
| T12 | 503-508 | GeneOrGeneProduct | denotes | NPHS2 |
| T13 | 536-545 | GeneOrGeneProduct | denotes | inducible |
| T14 | 550-561 | GeneOrGeneProduct | denotes | recombinase |
| T15 | 884-890 | GeneOrGeneProduct | denotes | fusion |
| T16 | 1361-1366 | GeneOrGeneProduct | denotes | early |
| T17 | 1395-1402 | GeneOrGeneProduct | denotes | podocin |
| T18 | 1403-1407 | GeneOrGeneProduct | denotes | mRNA |
| T19 | 1433-1440 | GeneOrGeneProduct | denotes | protein |
| T20 | 1455-1462 | GeneOrGeneProduct | denotes | reduced |
| T21 | 1525-1532 | GeneOrGeneProduct | denotes | miRNA21 |
| T22 | 1666-1675 | GeneOrGeneProduct | denotes | inducible |
| T23 | 1682-1689 | GeneOrGeneProduct | denotes | podocin |
| T24 | 1777-1785 | GeneOrGeneProduct | denotes | syndrome |
| T25 | 1928-1933 | GeneOrGeneProduct | denotes | novel |
| T26 | 2003-2012 | GeneOrGeneProduct | denotes | viability |
LitCoin-Disease-MeSH
| Id | Subject | Object | Predicate | Lexical cue | originalLabel |
|---|---|---|---|---|---|
| T1 | 53-71 | DiseaseOrPhenotypicFeature | denotes | nephrotic syndrome | D009404 |
| T2 | 137-155 | DiseaseOrPhenotypicFeature | denotes | nephrotic syndrome | D009404 |
| T3 | 223-230 | DiseaseOrPhenotypicFeature | denotes | disease | D004194 |
| T4 | 262-285 | DiseaseOrPhenotypicFeature | denotes | end-stage renal disease | D007676 |
| T5 | 413-426 | DiseaseOrPhenotypicFeature | denotes | renal failure | D051437 |
| T6 | 709-720 | DiseaseOrPhenotypicFeature | denotes | proteinuria | D011507 |
| T7 | 799-812 | DiseaseOrPhenotypicFeature | denotes | renal failure | D051437 |
| T8 | 986-993 | DiseaseOrPhenotypicFeature | denotes | disease | D004194 |
| T9 | 1148-1157 | DiseaseOrPhenotypicFeature | denotes | sclerosed | D012598 |
| T10 | 1250-1258 | DiseaseOrPhenotypicFeature | denotes | fibrosis | D005355 |
| T11 | 1280-1287 | DiseaseOrPhenotypicFeature | denotes | disease | D004194 |
| T12 | 1346-1357 | DiseaseOrPhenotypicFeature | denotes | proteinuria | D011507 |
| T13 | 1367-1374 | DiseaseOrPhenotypicFeature | denotes | disease | D004194 |
| T14 | 1767-1785 | DiseaseOrPhenotypicFeature | denotes | nephrotic syndrome | D009404 |
| T15 | 1806-1813 | DiseaseOrPhenotypicFeature | denotes | disease | D004194 |
| T16 | 2027-2038 | DiseaseOrPhenotypicFeature | denotes | proteinuria | D011507 |
| T17 | 2075-2088 | DiseaseOrPhenotypicFeature | denotes | renal failure | D051437 |
LitCoin-GeneOrGeneProduct-v3
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 28-35 | GeneOrGeneProduct | denotes | podocin |
| T2 | 90-95 | GeneOrGeneProduct | denotes | NPHS2 |
| T3 | 111-118 | GeneOrGeneProduct | denotes | podocin |
| T4 | 173-180 | GeneOrGeneProduct | denotes | podocin |
| T5 | 474-481 | GeneOrGeneProduct | denotes | podocin |
| T6 | 503-508 | GeneOrGeneProduct | denotes | NPHS2 |
| T7 | 1395-1402 | GeneOrGeneProduct | denotes | podocin |
| T8 | 1525-1532 | GeneOrGeneProduct | denotes | miRNA21 |
| T9 | 1682-1689 | GeneOrGeneProduct | denotes | podocin |
LitCoin_Mondo_095
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T1 | 53-71 | DiseaseOrPhenotypicFeature | denotes | nephrotic syndrome | 0005377 |
| T2 | 90-95 | DiseaseOrPhenotypicFeature | denotes | NPHS2 | 0044765|0010974 |
| T4 | 126-155 | DiseaseOrPhenotypicFeature | denotes | hereditary nephrotic syndrome | 0002350 |
| T5 | 262-285 | DiseaseOrPhenotypicFeature | denotes | end-stage renal disease | 0004375 |
| T6 | 413-426 | DiseaseOrPhenotypicFeature | denotes | renal failure | 0001106 |
| T7 | 503-508 | DiseaseOrPhenotypicFeature | denotes | NPHS2 | 0044765|0010974 |
| T9 | 709-720 | DiseaseOrPhenotypicFeature | denotes | proteinuria | 0003634 |
| T10 | 799-812 | DiseaseOrPhenotypicFeature | denotes | renal failure | 0001106 |
| T11 | 1346-1357 | DiseaseOrPhenotypicFeature | denotes | proteinuria | 0003634 |
| T12 | 1767-1785 | DiseaseOrPhenotypicFeature | denotes | nephrotic syndrome | 0005377 |
| T13 | 2027-2038 | DiseaseOrPhenotypicFeature | denotes | proteinuria | 0003634 |
| T14 | 2040-2058 | DiseaseOrPhenotypicFeature | denotes | glomerulosclerosis | 0000490 |
| T15 | 2075-2088 | DiseaseOrPhenotypicFeature | denotes | renal failure | 0001106 |
LitCoin-MeSH-Disease-2
| Id | Subject | Object | Predicate | Lexical cue | ID: |
|---|---|---|---|---|---|
| T1 | 53-71 | DiseaseOrPhenotypicFeature | denotes | nephrotic syndrome | D009404 |
| T2 | 137-155 | DiseaseOrPhenotypicFeature | denotes | nephrotic syndrome | D009404 |
| T3 | 223-230 | DiseaseOrPhenotypicFeature | denotes | disease | D004194 |
| T4 | 262-285 | DiseaseOrPhenotypicFeature | denotes | end-stage renal disease | D007676 |
| T5 | 413-426 | DiseaseOrPhenotypicFeature | denotes | renal failure | D051437 |
| T6 | 709-720 | DiseaseOrPhenotypicFeature | denotes | proteinuria | D011507 |
| T7 | 799-812 | DiseaseOrPhenotypicFeature | denotes | renal failure | D051437 |
| T8 | 986-993 | DiseaseOrPhenotypicFeature | denotes | disease | D004194 |
| T9 | 1250-1258 | DiseaseOrPhenotypicFeature | denotes | fibrosis | D005355 |
| T10 | 1280-1287 | DiseaseOrPhenotypicFeature | denotes | disease | D004194 |
| T11 | 1346-1357 | DiseaseOrPhenotypicFeature | denotes | proteinuria | D011507 |
| T12 | 1367-1374 | DiseaseOrPhenotypicFeature | denotes | disease | D004194 |
| T13 | 1767-1785 | DiseaseOrPhenotypicFeature | denotes | nephrotic syndrome | D009404 |
| T14 | 1806-1813 | DiseaseOrPhenotypicFeature | denotes | disease | D004194 |
| T15 | 2027-2038 | DiseaseOrPhenotypicFeature | denotes | proteinuria | D011507 |
| T16 | 2040-2058 | DiseaseOrPhenotypicFeature | denotes | glomerulosclerosis | DISEASE |
| T17 | 2075-2088 | DiseaseOrPhenotypicFeature | denotes | renal failure | D051437 |
LitCoin-MONDO_bioort2019
| Id | Subject | Object | Predicate | Lexical cue | #label |
|---|---|---|---|---|---|
| T1 | 53-71 | DiseaseOrPhenotypicFeature | denotes | nephrotic syndrome | D009404 |
| T2 | 137-155 | DiseaseOrPhenotypicFeature | denotes | nephrotic syndrome | D009404 |
| T3 | 262-285 | DiseaseOrPhenotypicFeature | denotes | end-stage renal disease | D007676 |
| T4 | 413-426 | DiseaseOrPhenotypicFeature | denotes | renal failure | D051437 |
| T5 | 709-720 | DiseaseOrPhenotypicFeature | denotes | proteinuria | D011507 |
| T6 | 799-812 | DiseaseOrPhenotypicFeature | denotes | renal failure | D051437 |
| T7 | 1250-1258 | DiseaseOrPhenotypicFeature | denotes | fibrosis | D005355 |
| T8 | 1346-1357 | DiseaseOrPhenotypicFeature | denotes | proteinuria | D011507 |
| T9 | 1767-1785 | DiseaseOrPhenotypicFeature | denotes | nephrotic syndrome | D009404 |
| T10 | 2027-2038 | DiseaseOrPhenotypicFeature | denotes | proteinuria | D011507 |
| T11 | 2040-2058 | DiseaseOrPhenotypicFeature | denotes | glomerulosclerosis | DISEASE |
| T12 | 2075-2088 | DiseaseOrPhenotypicFeature | denotes | renal failure | D051437 |
LitCoin-NCBITaxon-2
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 13-18 | OrganismTaxon | denotes | mouse |
| T2 | 296-300 | OrganismTaxon | denotes | mice |
| T3 | 332-337 | OrganismTaxon | denotes | mouse |
| T4 | 350-355 | OrganismTaxon | denotes | human |
| T5 | 1690-1695 | OrganismTaxon | denotes | mouse |
| T6 | 1761-1766 | OrganismTaxon | denotes | human |
| T7 | 1849-1854 | OrganismTaxon | denotes | human |
LitCoin-Chemical-MeSH-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | ID: |
|---|---|---|---|---|---|
| T1 | 526-535 | ChemicalEntity | denotes | tamoxifen | D013629|http://purl.obolibrary.org/obo/CHEBI_41774 |
| T3 | 546-561 | ChemicalEntity | denotes | Cre recombinase | C045073 |
LitCoin-training-merged
| Id | Subject | Object | Predicate | Lexical cue | #label | ID: |
|---|---|---|---|---|---|---|
| T3 | 546-561 | ChemicalEntity | denotes | Cre recombinase | C045073 | |
| T1 | 526-535 | ChemicalEntity | denotes | tamoxifen | http://purl.obolibrary.org/obo/CHEBI_41774|D013629 | |
| T9 | 1682-1689 | GeneOrGeneProduct | denotes | podocin | ||
| T8 | 1525-1532 | GeneOrGeneProduct | denotes | miRNA21 | ||
| T7 | 1395-1402 | GeneOrGeneProduct | denotes | podocin | ||
| T6 | 503-508 | GeneOrGeneProduct | denotes | NPHS2 | ||
| T5 | 474-481 | GeneOrGeneProduct | denotes | podocin | ||
| T4 | 173-180 | GeneOrGeneProduct | denotes | podocin | ||
| T10911 | 111-118 | GeneOrGeneProduct | denotes | podocin | ||
| T2 | 90-95 | GeneOrGeneProduct | denotes | NPHS2 | ||
| T12364 | 28-35 | GeneOrGeneProduct | denotes | podocin | ||
| T12 | 2075-2088 | DiseaseOrPhenotypicFeature | denotes | renal failure | D051437 | |
| T11 | 2040-2058 | DiseaseOrPhenotypicFeature | denotes | glomerulosclerosis | DISEASE | |
| T10 | 2027-2038 | DiseaseOrPhenotypicFeature | denotes | proteinuria | D011507 | |
| T45427 | 1767-1785 | DiseaseOrPhenotypicFeature | denotes | nephrotic syndrome | D009404 | |
| T53049 | 1346-1357 | DiseaseOrPhenotypicFeature | denotes | proteinuria | D011507 | |
| T63547 | 1250-1258 | DiseaseOrPhenotypicFeature | denotes | fibrosis | D005355 | |
| T28747 | 799-812 | DiseaseOrPhenotypicFeature | denotes | renal failure | D051437 | |
| T95215 | 709-720 | DiseaseOrPhenotypicFeature | denotes | proteinuria | D011507 | |
| T70014 | 413-426 | DiseaseOrPhenotypicFeature | denotes | renal failure | D051437 | |
| T19913 | 262-285 | DiseaseOrPhenotypicFeature | denotes | end-stage renal disease | D007676 | |
| T41330 | 137-155 | DiseaseOrPhenotypicFeature | denotes | nephrotic syndrome | D009404 | |
| T24073 | 53-71 | DiseaseOrPhenotypicFeature | denotes | nephrotic syndrome | D009404 | |
| T23115 | 1849-1854 | OrganismTaxon | denotes | human | ||
| T40596 | 1761-1766 | OrganismTaxon | denotes | human | ||
| T64328 | 1690-1695 | OrganismTaxon | denotes | mouse | ||
| T89878 | 350-355 | OrganismTaxon | denotes | human | ||
| T53346 | 332-337 | OrganismTaxon | denotes | mouse | ||
| T57397 | 296-300 | OrganismTaxon | denotes | mice | ||
| T15197 | 13-18 | OrganismTaxon | denotes | mouse | ||
| T74446 | 1676-1681 | SequenceVariant | denotes | R140Q | ||
| T82552 | 1389-1394 | SequenceVariant | denotes | R140Q | ||
| T80913 | 658-663 | SequenceVariant | denotes | R140Q | ||
| T82040 | 509-514 | SequenceVariant | denotes | R140Q | ||
| T66714 | 356-361 | SequenceVariant | denotes | R138Q | ||
| T35876 | 312-317 | SequenceVariant | denotes | R140Q | ||
| T66323 | 191-196 | SequenceVariant | denotes | R138Q |
biored-valid-deepseek-nr-ng
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 28-35 | GeneOrGeneProduct | denotes | podocin |
| T2 | 90-95 | GeneOrGeneProduct | denotes | NPHS2 |
| T3 | 191-196 | SequenceVariant | denotes | R138Q |
| T4 | 312-317 | SequenceVariant | denotes | R140Q |
| T5 | 1389-1394 | SequenceVariant | denotes | R140Q |
| T6 | 1395-1402 | GeneOrGeneProduct | denotes | podocin |
| T7 | 1525-1532 | GeneOrGeneProduct | denotes | miRNA21 |
| T8 | 1593-1603 | GeneOrGeneProduct | denotes | miRNA-193a |
biored-valid
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 13-18 | OrganismTaxon | denotes | mouse |
| T2 | 28-35 | GeneOrGeneProduct | denotes | podocin |
| T3 | 53-71 | DiseaseOrPhenotypicFeature | denotes | nephrotic syndrome |
| T4 | 90-95 | GeneOrGeneProduct | denotes | NPHS2 |
| T5 | 111-118 | GeneOrGeneProduct | denotes | podocin |
| T6 | 137-155 | DiseaseOrPhenotypicFeature | denotes | nephrotic syndrome |
| T7 | 173-180 | GeneOrGeneProduct | denotes | podocin |
| T8 | 191-196 | SequenceVariant | denotes | R138Q |
| T9 | 272-285 | DiseaseOrPhenotypicFeature | denotes | renal disease |
| T10 | 296-300 | OrganismTaxon | denotes | mice |
| T11 | 312-317 | SequenceVariant | denotes | R140Q |
| T12 | 332-337 | OrganismTaxon | denotes | mouse |
| T13 | 350-355 | OrganismTaxon | denotes | human |
| T14 | 356-361 | SequenceVariant | denotes | R138Q |
| T15 | 413-426 | DiseaseOrPhenotypicFeature | denotes | renal failure |
| T16 | 474-481 | GeneOrGeneProduct | denotes | podocin |
| T17 | 503-508 | GeneOrGeneProduct | denotes | NPHS2 |
| T18 | 509-514 | SequenceVariant | denotes | R140Q |
| T19 | 526-535 | ChemicalEntity | denotes | tamoxifen |
| T20 | 658-663 | SequenceVariant | denotes | R140Q |
| T21 | 709-720 | DiseaseOrPhenotypicFeature | denotes | proteinuria |
| T22 | 799-812 | DiseaseOrPhenotypicFeature | denotes | renal failure |
| T23 | 1231-1258 | DiseaseOrPhenotypicFeature | denotes | tubulointerstitial fibrosis |
| T24 | 1346-1357 | DiseaseOrPhenotypicFeature | denotes | proteinuria |
| T25 | 1389-1394 | SequenceVariant | denotes | R140Q |
| T26 | 1395-1402 | GeneOrGeneProduct | denotes | podocin |
| T27 | 1525-1532 | GeneOrGeneProduct | denotes | miRNA21 |
| T28 | 1593-1603 | GeneOrGeneProduct | denotes | miRNA-193a |
| T29 | 1676-1681 | SequenceVariant | denotes | R140Q |
| T30 | 1682-1689 | GeneOrGeneProduct | denotes | podocin |
| T31 | 1690-1695 | OrganismTaxon | denotes | mouse |
| T32 | 1761-1766 | OrganismTaxon | denotes | human |
| T33 | 1767-1785 | DiseaseOrPhenotypicFeature | denotes | nephrotic syndrome |
| T34 | 1849-1854 | OrganismTaxon | denotes | human |
| T35 | 2027-2038 | DiseaseOrPhenotypicFeature | denotes | proteinuria |
| T36 | 2040-2058 | DiseaseOrPhenotypicFeature | denotes | glomerulosclerosis |
| T37 | 2075-2088 | DiseaseOrPhenotypicFeature | denotes | renal failure |
biored-valid-deepseek-nr-g
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 13-18 | OrganismTaxon | denotes | mouse |
| T2 | 28-35 | GeneOrGeneProduct | denotes | podocin |
| T3 | 90-95 | GeneOrGeneProduct | denotes | NPHS2 |
| T4 | 111-118 | GeneOrGeneProduct | denotes | podocin |
| T5 | 126-155 | DiseaseOrPhenotypicFeature | denotes | hereditary nephrotic syndrome |
| T6 | 173-180 | GeneOrGeneProduct | denotes | podocin |
| T7 | 191-196 | SequenceVariant | denotes | R138Q |
| T8 | 262-285 | DiseaseOrPhenotypicFeature | denotes | end-stage renal disease |
| T9 | 296-300 | OrganismTaxon | denotes | mice |
| T10 | 312-317 | SequenceVariant | denotes | R140Q |
| T11 | 332-337 | OrganismTaxon | denotes | mouse |
| T12 | 350-355 | OrganismTaxon | denotes | human |
| T13 | 356-361 | SequenceVariant | denotes | R138Q |
| T14 | 368-388 | DiseaseOrPhenotypicFeature | denotes | developmental arrest |
| T15 | 392-401 | CellLine | denotes | podocytes |
| T16 | 406-426 | DiseaseOrPhenotypicFeature | denotes | lethal renal failure |
| T17 | 430-442 | DiseaseOrPhenotypicFeature | denotes | neonatal age |
| T18 | 474-481 | GeneOrGeneProduct | denotes | podocin |
| T19 | 503-508 | GeneOrGeneProduct | denotes | NPHS2 |
| T20 | 509-514 | SequenceVariant | denotes | R140Q |
| T21 | 526-545 | ChemicalEntity | denotes | tamoxifen-inducible |
| T22 | 546-549 | GeneOrGeneProduct | denotes | Cre |
| T23 | 550-561 | GeneOrGeneProduct | denotes | recombinase |
| T24 | 658-663 | SequenceVariant | denotes | R140Q |
| T25 | 664-676 | DiseaseOrPhenotypicFeature | denotes | hemizygosity |
| T26 | 709-720 | DiseaseOrPhenotypicFeature | denotes | proteinuria |
| T27 | 787-812 | DiseaseOrPhenotypicFeature | denotes | progressive renal failure |
| T28 | 871-890 | DiseaseOrPhenotypicFeature | denotes | Foot process fusion |
| T29 | 936-964 | DiseaseOrPhenotypicFeature | denotes | severe and global effacement |
| T30 | 1009-1018 | CellLine | denotes | podocytes |
| T31 | 1023-1033 | DiseaseOrPhenotypicFeature | denotes | glomerulus |
| T32 | 1136-1167 | DiseaseOrPhenotypicFeature | denotes | segmentally sclerosed glomeruli |
| T33 | 1224-1258 | DiseaseOrPhenotypicFeature | denotes | Severe tubulointerstitial fibrosis |
| T34 | 1346-1357 | DiseaseOrPhenotypicFeature | denotes | proteinuria |
| T35 | 1389-1394 | SequenceVariant | denotes | R140Q |
| T36 | 1395-1402 | GeneOrGeneProduct | denotes | podocin |
| T37 | 1403-1407 | GeneOrGeneProduct | denotes | mRNA |
| T38 | 1525-1532 | GeneOrGeneProduct | denotes | miRNA21 |
| T39 | 1593-1603 | GeneOrGeneProduct | denotes | miRNA-193a |
| T40 | 1690-1695 | OrganismTaxon | denotes | mouse |
| T41 | 1761-1785 | DiseaseOrPhenotypicFeature | denotes | human nephrotic syndrome |
| T42 | 1849-1863 | DiseaseOrPhenotypicFeature | denotes | human disorder |
| T43 | 1981-1989 | CellLine | denotes | podocyte |
| T44 | 2040-2058 | DiseaseOrPhenotypicFeature | denotes | glomerulosclerosis |
| T45 | 2063-2088 | DiseaseOrPhenotypicFeature | denotes | progressive renal failure |
biored-valid-deepseek-r-ng
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 13-18 | OrganismTaxon | denotes | mouse |
| T2 | 28-35 | GeneOrGeneProduct | denotes | podocin |
| T3 | 53-71 | DiseaseOrPhenotypicFeature | denotes | nephrotic syndrome |
| T4 | 90-100 | GeneOrGeneProduct | denotes | NPHS2 gene |
| T5 | 191-196 | SequenceVariant | denotes | R138Q |
| T6 | 262-285 | DiseaseOrPhenotypicFeature | denotes | end-stage renal disease |
| T7 | 312-317 | SequenceVariant | denotes | R140Q |
| T8 | 350-355 | OrganismTaxon | denotes | human |
| T9 | 413-426 | DiseaseOrPhenotypicFeature | denotes | renal failure |
| T10 | 526-535 | ChemicalEntity | denotes | tamoxifen |
| T11 | 546-561 | GeneOrGeneProduct | denotes | Cre recombinase |
| T12 | 709-720 | DiseaseOrPhenotypicFeature | denotes | proteinuria |
| T13 | 1250-1258 | DiseaseOrPhenotypicFeature | denotes | fibrosis |
| T14 | 1525-1532 | GeneOrGeneProduct | denotes | miRNA21 |
| T15 | 1593-1603 | GeneOrGeneProduct | denotes | miRNA-193a |
| T16 | 2040-2058 | DiseaseOrPhenotypicFeature | denotes | glomerulosclerosis |
biored-valid-deepseek-r-g
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 13-18 | OrganismTaxon | denotes | mouse |
| T2 | 28-35 | GeneOrGeneProduct | denotes | podocin |
| T3 | 53-71 | DiseaseOrPhenotypicFeature | denotes | nephrotic syndrome |
| T4 | 90-95 | GeneOrGeneProduct | denotes | NPHS2 |
| T5 | 111-118 | GeneOrGeneProduct | denotes | podocin |
| T6 | 126-155 | DiseaseOrPhenotypicFeature | denotes | hereditary nephrotic syndrome |
| T7 | 191-196 | SequenceVariant | denotes | R138Q |
| T8 | 262-285 | DiseaseOrPhenotypicFeature | denotes | end-stage renal disease |
| T9 | 312-317 | SequenceVariant | denotes | R140Q |
| T10 | 332-337 | OrganismTaxon | denotes | mouse |
| T11 | 350-355 | OrganismTaxon | denotes | human |
| T12 | 526-535 | ChemicalEntity | denotes | tamoxifen |
| T13 | 546-561 | GeneOrGeneProduct | denotes | Cre recombinase |
| T14 | 709-720 | DiseaseOrPhenotypicFeature | denotes | proteinuria |
| T15 | 787-812 | DiseaseOrPhenotypicFeature | denotes | progressive renal failure |
| T16 | 1136-1167 | DiseaseOrPhenotypicFeature | denotes | segmentally sclerosed glomeruli |
| T17 | 1231-1258 | DiseaseOrPhenotypicFeature | denotes | tubulointerstitial fibrosis |
| T18 | 1525-1532 | GeneOrGeneProduct | denotes | miRNA21 |
| T19 | 1593-1603 | GeneOrGeneProduct | denotes | miRNA-193a |
| T20 | 1761-1785 | DiseaseOrPhenotypicFeature | denotes | human nephrotic syndrome |
| T21 | 2040-2058 | DiseaseOrPhenotypicFeature | denotes | glomerulosclerosis |
biored-valid-gemini-nr-ng
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 13-18 | OrganismTaxon | denotes | mouse |
| T2 | 28-71 | DiseaseOrPhenotypicFeature | denotes | podocin-mutation-related nephrotic syndrome |
| T3 | 90-95 | GeneOrGeneProduct | denotes | NPHS2 |
| T4 | 111-118 | GeneOrGeneProduct | denotes | podocin |
| T5 | 126-155 | DiseaseOrPhenotypicFeature | denotes | hereditary nephrotic syndrome |
| T6 | 173-180 | GeneOrGeneProduct | denotes | podocin |
| T7 | 181-189 | SequenceVariant | denotes | mutation |
| T8 | 191-196 | SequenceVariant | denotes | R138Q |
| T9 | 217-236 | DiseaseOrPhenotypicFeature | denotes | early disease onset |
| T10 | 262-285 | DiseaseOrPhenotypicFeature | denotes | end-stage renal disease |
| T11 | 287-295 | SequenceVariant | denotes | Knock-in |
| T12 | 296-300 | OrganismTaxon | denotes | mice |
| T13 | 312-317 | SequenceVariant | denotes | R140Q |
| T14 | 318-326 | SequenceVariant | denotes | mutation |
| T15 | 332-337 | OrganismTaxon | denotes | mouse |
| T16 | 350-355 | OrganismTaxon | denotes | human |
| T17 | 356-361 | SequenceVariant | denotes | R138Q |
| T18 | 368-388 | DiseaseOrPhenotypicFeature | denotes | developmental arrest |
| T19 | 406-426 | DiseaseOrPhenotypicFeature | denotes | lethal renal failure |
| T20 | 474-481 | GeneOrGeneProduct | denotes | podocin |
| T21 | 482-490 | SequenceVariant | denotes | knock-in |
| T22 | 503-508 | GeneOrGeneProduct | denotes | NPHS2 |
| T23 | 509-514 | SequenceVariant | denotes | R140Q |
| T24 | 526-535 | ChemicalEntity | denotes | tamoxifen |
| T25 | 546-561 | GeneOrGeneProduct | denotes | Cre recombinase |
| T26 | 605-613 | SequenceVariant | denotes | mutation |
| T27 | 664-686 | SequenceVariant | denotes | hemizygosity induction |
| T28 | 709-720 | DiseaseOrPhenotypicFeature | denotes | proteinuria |
| T29 | 787-812 | DiseaseOrPhenotypicFeature | denotes | progressive renal failure |
| T30 | 871-890 | DiseaseOrPhenotypicFeature | denotes | Foot process fusion |
| T31 | 936-967 | DiseaseOrPhenotypicFeature | denotes | severe and global effacement in |
| T32 | 1136-1157 | DiseaseOrPhenotypicFeature | denotes | segmentally sclerosed |
| T33 | 1231-1258 | DiseaseOrPhenotypicFeature | denotes | tubulointerstitial fibrosis |
| T34 | 1346-1357 | DiseaseOrPhenotypicFeature | denotes | proteinuria |
| T35 | 1389-1394 | SequenceVariant | denotes | R140Q |
| T36 | 1395-1402 | GeneOrGeneProduct | denotes | podocin |
| T37 | 1403-1418 | GeneOrGeneProduct | denotes | mRNA expression |
| T38 | 1525-1532 | GeneOrGeneProduct | denotes | miRNA21 |
| T39 | 1593-1603 | GeneOrGeneProduct | denotes | miRNA-193a |
| T40 | 1690-1695 | OrganismTaxon | denotes | mouse |
| T41 | 1761-1766 | OrganismTaxon | denotes | human |
| T42 | 1767-1785 | DiseaseOrPhenotypicFeature | denotes | nephrotic syndrome |
| T43 | 2027-2038 | DiseaseOrPhenotypicFeature | denotes | proteinuria |
| T44 | 2040-2058 | DiseaseOrPhenotypicFeature | denotes | glomerulosclerosis |
| T45 | 2063-2088 | DiseaseOrPhenotypicFeature | denotes | progressive renal failure |
biored-valid-gemini-r-ng
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 13-18 | OrganismTaxon | denotes | mouse |
| T2 | 28-35 | GeneOrGeneProduct | denotes | podocin |
| T3 | 53-71 | DiseaseOrPhenotypicFeature | denotes | nephrotic syndrome |
| T4 | 90-100 | GeneOrGeneProduct | denotes | NPHS2 gene |
| T5 | 111-118 | GeneOrGeneProduct | denotes | podocin |
| T6 | 126-155 | DiseaseOrPhenotypicFeature | denotes | hereditary nephrotic syndrome |
| T7 | 173-180 | GeneOrGeneProduct | denotes | podocin |
| T8 | 191-196 | SequenceVariant | denotes | R138Q |
| T9 | 217-236 | DiseaseOrPhenotypicFeature | denotes | early disease onset |
| T10 | 262-285 | DiseaseOrPhenotypicFeature | denotes | end-stage renal disease |
| T11 | 296-300 | OrganismTaxon | denotes | mice |
| T12 | 312-317 | SequenceVariant | denotes | R140Q |
| T13 | 332-337 | OrganismTaxon | denotes | mouse |
| T14 | 350-355 | OrganismTaxon | denotes | human |
| T15 | 356-361 | SequenceVariant | denotes | R138Q |
| T16 | 368-401 | DiseaseOrPhenotypicFeature | denotes | developmental arrest of podocytes |
| T17 | 406-426 | DiseaseOrPhenotypicFeature | denotes | lethal renal failure |
| T18 | 474-481 | GeneOrGeneProduct | denotes | podocin |
| T19 | 503-508 | GeneOrGeneProduct | denotes | NPHS2 |
| T20 | 509-514 | SequenceVariant | denotes | R140Q |
| T21 | 526-535 | ChemicalEntity | denotes | tamoxifen |
| T22 | 546-561 | GeneOrGeneProduct | denotes | Cre recombinase |
| T23 | 658-676 | DiseaseOrPhenotypicFeature | denotes | R140Q hemizygosity |
| T24 | 709-720 | DiseaseOrPhenotypicFeature | denotes | proteinuria |
| T25 | 787-812 | DiseaseOrPhenotypicFeature | denotes | progressive renal failure |
| T26 | 871-890 | DiseaseOrPhenotypicFeature | denotes | Foot process fusion |
| T27 | 936-964 | DiseaseOrPhenotypicFeature | denotes | severe and global effacement |
| T28 | 1136-1167 | DiseaseOrPhenotypicFeature | denotes | segmentally sclerosed glomeruli |
| T29 | 1224-1258 | DiseaseOrPhenotypicFeature | denotes | Severe tubulointerstitial fibrosis |
| T30 | 1346-1357 | DiseaseOrPhenotypicFeature | denotes | proteinuria |
| T31 | 1389-1394 | SequenceVariant | denotes | R140Q |
| T32 | 1395-1402 | GeneOrGeneProduct | denotes | podocin |
| T33 | 1403-1407 | ChemicalEntity | denotes | mRNA |
| T34 | 1525-1532 | GeneOrGeneProduct | denotes | miRNA21 |
| T35 | 1593-1603 | GeneOrGeneProduct | denotes | miRNA-193a |
| T36 | 1676-1681 | SequenceVariant | denotes | R140Q |
| T37 | 1682-1689 | GeneOrGeneProduct | denotes | podocin |
| T38 | 1690-1695 | OrganismTaxon | denotes | mouse |
| T39 | 1761-1766 | OrganismTaxon | denotes | human |
| T40 | 1767-1785 | DiseaseOrPhenotypicFeature | denotes | nephrotic syndrome |
| T41 | 2027-2038 | DiseaseOrPhenotypicFeature | denotes | proteinuria |
| T42 | 2040-2058 | DiseaseOrPhenotypicFeature | denotes | glomerulosclerosis |
| T43 | 2063-2088 | DiseaseOrPhenotypicFeature | denotes | progressive renal failure |
biored-valid-gemini-r-g
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 13-18 | OrganismTaxon | denotes | mouse |
| T2 | 28-35 | GeneOrGeneProduct | denotes | podocin |
| T3 | 53-71 | DiseaseOrPhenotypicFeature | denotes | nephrotic syndrome |
| T4 | 90-95 | GeneOrGeneProduct | denotes | NPHS2 |
| T5 | 111-118 | GeneOrGeneProduct | denotes | podocin |
| T6 | 137-155 | DiseaseOrPhenotypicFeature | denotes | nephrotic syndrome |
| T7 | 173-180 | GeneOrGeneProduct | denotes | podocin |
| T8 | 191-196 | SequenceVariant | denotes | R138Q |
| T9 | 262-285 | DiseaseOrPhenotypicFeature | denotes | end-stage renal disease |
| T10 | 296-300 | OrganismTaxon | denotes | mice |
| T11 | 312-317 | SequenceVariant | denotes | R140Q |
| T12 | 332-337 | OrganismTaxon | denotes | mouse |
| T13 | 350-355 | OrganismTaxon | denotes | human |
| T14 | 356-361 | SequenceVariant | denotes | R138Q |
| T15 | 413-426 | DiseaseOrPhenotypicFeature | denotes | renal failure |
| T16 | 474-481 | GeneOrGeneProduct | denotes | podocin |
| T17 | 503-508 | GeneOrGeneProduct | denotes | NPHS2 |
| T18 | 509-514 | SequenceVariant | denotes | R140Q |
| T19 | 526-535 | ChemicalEntity | denotes | tamoxifen |
| T20 | 546-561 | GeneOrGeneProduct | denotes | Cre recombinase |
| T21 | 658-663 | SequenceVariant | denotes | R140Q |
| T22 | 709-720 | DiseaseOrPhenotypicFeature | denotes | proteinuria |
| T23 | 799-812 | DiseaseOrPhenotypicFeature | denotes | renal failure |
| T24 | 871-890 | DiseaseOrPhenotypicFeature | denotes | Foot process fusion |
| T25 | 954-964 | DiseaseOrPhenotypicFeature | denotes | effacement |
| T26 | 1148-1167 | DiseaseOrPhenotypicFeature | denotes | sclerosed glomeruli |
| T27 | 1231-1258 | DiseaseOrPhenotypicFeature | denotes | tubulointerstitial fibrosis |
| T28 | 1346-1357 | DiseaseOrPhenotypicFeature | denotes | proteinuria |
| T29 | 1389-1394 | SequenceVariant | denotes | R140Q |
| T30 | 1395-1402 | GeneOrGeneProduct | denotes | podocin |
| T31 | 1525-1532 | GeneOrGeneProduct | denotes | miRNA21 |
| T32 | 1593-1603 | GeneOrGeneProduct | denotes | miRNA-193a |
| T33 | 1676-1681 | SequenceVariant | denotes | R140Q |
| T34 | 1682-1689 | GeneOrGeneProduct | denotes | podocin |
| T35 | 1690-1695 | OrganismTaxon | denotes | mouse |
| T36 | 1761-1766 | OrganismTaxon | denotes | human |
| T37 | 1767-1785 | DiseaseOrPhenotypicFeature | denotes | nephrotic syndrome |
| T38 | 2027-2038 | DiseaseOrPhenotypicFeature | denotes | proteinuria |
| T39 | 2040-2058 | DiseaseOrPhenotypicFeature | denotes | glomerulosclerosis |
| T40 | 2075-2088 | DiseaseOrPhenotypicFeature | denotes | renal failure |
biored-valid-gpt-nr-ng
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 13-18 | OrganismTaxon | denotes | mouse |
| T2 | 53-71 | DiseaseOrPhenotypicFeature | denotes | nephrotic syndrome |
| T3 | 90-95 | GeneOrGeneProduct | denotes | NPHS2 |
| T4 | 111-118 | GeneOrGeneProduct | denotes | podocin |
| T5 | 126-155 | DiseaseOrPhenotypicFeature | denotes | hereditary nephrotic syndrome |
| T6 | 173-180 | GeneOrGeneProduct | denotes | podocin |
| T7 | 191-196 | SequenceVariant | denotes | R138Q |
| T8 | 262-285 | DiseaseOrPhenotypicFeature | denotes | end-stage renal disease |
| T9 | 296-300 | OrganismTaxon | denotes | mice |
| T10 | 312-317 | SequenceVariant | denotes | R140Q |
| T11 | 332-337 | OrganismTaxon | denotes | mouse |
| T12 | 350-355 | OrganismTaxon | denotes | human |
| T13 | 356-361 | SequenceVariant | denotes | R138Q |
| T14 | 368-401 | DiseaseOrPhenotypicFeature | denotes | developmental arrest of podocytes |
| T15 | 406-426 | DiseaseOrPhenotypicFeature | denotes | lethal renal failure |
| T16 | 474-481 | GeneOrGeneProduct | denotes | podocin |
| T17 | 503-508 | GeneOrGeneProduct | denotes | NPHS2 |
| T18 | 509-516 | SequenceVariant | denotes | R140Q/- |
| T19 | 526-535 | ChemicalEntity | denotes | tamoxifen |
| T20 | 546-561 | GeneOrGeneProduct | denotes | Cre recombinase |
| T21 | 658-663 | SequenceVariant | denotes | R140Q |
| T22 | 709-720 | DiseaseOrPhenotypicFeature | denotes | proteinuria |
| T23 | 787-812 | DiseaseOrPhenotypicFeature | denotes | progressive renal failure |
| T24 | 871-890 | DiseaseOrPhenotypicFeature | denotes | Foot process fusion |
| T25 | 954-964 | DiseaseOrPhenotypicFeature | denotes | effacement |
| T26 | 1231-1258 | DiseaseOrPhenotypicFeature | denotes | tubulointerstitial fibrosis |
| T27 | 1346-1357 | DiseaseOrPhenotypicFeature | denotes | proteinuria |
| T28 | 1389-1394 | SequenceVariant | denotes | R140Q |
| T29 | 1395-1407 | GeneOrGeneProduct | denotes | podocin mRNA |
| T30 | 1525-1532 | GeneOrGeneProduct | denotes | miRNA21 |
| T31 | 1593-1603 | GeneOrGeneProduct | denotes | miRNA-193a |
| T32 | 1690-1695 | OrganismTaxon | denotes | mouse |
| T33 | 1761-1766 | OrganismTaxon | denotes | human |
| T34 | 1767-1785 | DiseaseOrPhenotypicFeature | denotes | nephrotic syndrome |
| T35 | 1849-1854 | OrganismTaxon | denotes | human |
| T36 | 2027-2038 | DiseaseOrPhenotypicFeature | denotes | proteinuria |
| T37 | 2040-2058 | DiseaseOrPhenotypicFeature | denotes | glomerulosclerosis |
| T38 | 2063-2088 | DiseaseOrPhenotypicFeature | denotes | progressive renal failure |
biored-valid-gpt-nr-g
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 53-71 | DiseaseOrPhenotypicFeature | denotes | nephrotic syndrome |
| T2 | 90-95 | GeneOrGeneProduct | denotes | NPHS2 |
| T3 | 111-118 | GeneOrGeneProduct | denotes | podocin |
| T4 | 137-155 | DiseaseOrPhenotypicFeature | denotes | nephrotic syndrome |
| T5 | 173-180 | GeneOrGeneProduct | denotes | podocin |
| T6 | 191-196 | SequenceVariant | denotes | R138Q |
| T7 | 262-285 | DiseaseOrPhenotypicFeature | denotes | end-stage renal disease |
| T8 | 296-300 | OrganismTaxon | denotes | mice |
| T9 | 312-317 | SequenceVariant | denotes | R140Q |
| T10 | 332-337 | OrganismTaxon | denotes | mouse |
| T11 | 350-355 | OrganismTaxon | denotes | human |
| T12 | 356-361 | SequenceVariant | denotes | R138Q |
| T13 | 413-426 | DiseaseOrPhenotypicFeature | denotes | renal failure |
| T14 | 474-481 | GeneOrGeneProduct | denotes | podocin |
| T15 | 503-508 | GeneOrGeneProduct | denotes | NPHS2 |
| T16 | 509-516 | SequenceVariant | denotes | R140Q/- |
| T17 | 526-535 | ChemicalEntity | denotes | tamoxifen |
| T18 | 546-561 | GeneOrGeneProduct | denotes | Cre recombinase |
| T19 | 658-663 | SequenceVariant | denotes | R140Q |
| T20 | 709-720 | DiseaseOrPhenotypicFeature | denotes | proteinuria |
| T21 | 799-812 | DiseaseOrPhenotypicFeature | denotes | renal failure |
| T22 | 1231-1258 | DiseaseOrPhenotypicFeature | denotes | tubulointerstitial fibrosis |
| T23 | 1346-1357 | DiseaseOrPhenotypicFeature | denotes | proteinuria |
| T24 | 1389-1394 | SequenceVariant | denotes | R140Q |
| T25 | 1395-1402 | GeneOrGeneProduct | denotes | podocin |
| T26 | 1525-1532 | GeneOrGeneProduct | denotes | miRNA21 |
| T27 | 1593-1603 | GeneOrGeneProduct | denotes | miRNA-193a |
| T28 | 1690-1695 | OrganismTaxon | denotes | mouse |
| T29 | 1761-1766 | OrganismTaxon | denotes | human |
| T30 | 1767-1785 | DiseaseOrPhenotypicFeature | denotes | nephrotic syndrome |
| T31 | 1849-1854 | OrganismTaxon | denotes | human |
| T32 | 2027-2038 | DiseaseOrPhenotypicFeature | denotes | proteinuria |
| T33 | 2040-2058 | DiseaseOrPhenotypicFeature | denotes | glomerulosclerosis |
| T34 | 2075-2088 | DiseaseOrPhenotypicFeature | denotes | renal failure |
biored-valid-gpt-r-g
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 13-18 | OrganismTaxon | denotes | mouse |
| T2 | 28-35 | GeneOrGeneProduct | denotes | podocin |
| T3 | 53-71 | DiseaseOrPhenotypicFeature | denotes | nephrotic syndrome |
| T4 | 90-95 | GeneOrGeneProduct | denotes | NPHS2 |
| T5 | 111-118 | GeneOrGeneProduct | denotes | podocin |
| T6 | 137-155 | DiseaseOrPhenotypicFeature | denotes | nephrotic syndrome |
| T7 | 173-180 | GeneOrGeneProduct | denotes | podocin |
| T8 | 191-196 | SequenceVariant | denotes | R138Q |
| T9 | 262-285 | DiseaseOrPhenotypicFeature | denotes | end-stage renal disease |
| T10 | 296-300 | OrganismTaxon | denotes | mice |
| T11 | 312-317 | SequenceVariant | denotes | R140Q |
| T12 | 332-337 | OrganismTaxon | denotes | mouse |
| T13 | 350-355 | OrganismTaxon | denotes | human |
| T14 | 356-361 | SequenceVariant | denotes | R138Q |
| T15 | 368-401 | DiseaseOrPhenotypicFeature | denotes | developmental arrest of podocytes |
| T16 | 413-426 | DiseaseOrPhenotypicFeature | denotes | renal failure |
| T17 | 474-481 | GeneOrGeneProduct | denotes | podocin |
| T18 | 503-508 | GeneOrGeneProduct | denotes | NPHS2 |
| T19 | 509-516 | SequenceVariant | denotes | R140Q/- |
| T20 | 526-535 | ChemicalEntity | denotes | tamoxifen |
| T21 | 546-561 | GeneOrGeneProduct | denotes | Cre recombinase |
| T22 | 658-663 | SequenceVariant | denotes | R140Q |
| T23 | 709-720 | DiseaseOrPhenotypicFeature | denotes | proteinuria |
| T24 | 799-812 | DiseaseOrPhenotypicFeature | denotes | renal failure |
| T25 | 871-890 | DiseaseOrPhenotypicFeature | denotes | Foot process fusion |
| T26 | 954-964 | DiseaseOrPhenotypicFeature | denotes | effacement |
| T27 | 1136-1167 | DiseaseOrPhenotypicFeature | denotes | segmentally sclerosed glomeruli |
| T28 | 1231-1258 | DiseaseOrPhenotypicFeature | denotes | tubulointerstitial fibrosis |
| T29 | 1346-1357 | DiseaseOrPhenotypicFeature | denotes | proteinuria |
| T30 | 1389-1394 | SequenceVariant | denotes | R140Q |
| T31 | 1395-1407 | GeneOrGeneProduct | denotes | podocin mRNA |
| T32 | 1525-1532 | GeneOrGeneProduct | denotes | miRNA21 |
| T33 | 1593-1603 | GeneOrGeneProduct | denotes | miRNA-193a |
| T34 | 1676-1681 | SequenceVariant | denotes | R140Q |
| T35 | 1682-1689 | GeneOrGeneProduct | denotes | podocin |
| T36 | 1690-1695 | OrganismTaxon | denotes | mouse |
| T37 | 1761-1766 | OrganismTaxon | denotes | human |
| T38 | 1767-1785 | DiseaseOrPhenotypicFeature | denotes | nephrotic syndrome |
| T39 | 2027-2038 | DiseaseOrPhenotypicFeature | denotes | proteinuria |
| T40 | 2040-2058 | DiseaseOrPhenotypicFeature | denotes | glomerulosclerosis |
| T41 | 2075-2088 | DiseaseOrPhenotypicFeature | denotes | renal failure |
biored-valid-gpt-r-ng
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 13-18 | OrganismTaxon | denotes | mouse |
| T2 | 28-35 | GeneOrGeneProduct | denotes | podocin |
| T3 | 53-71 | DiseaseOrPhenotypicFeature | denotes | nephrotic syndrome |
| T4 | 90-95 | GeneOrGeneProduct | denotes | NPHS2 |
| T5 | 111-118 | GeneOrGeneProduct | denotes | podocin |
| T6 | 126-155 | DiseaseOrPhenotypicFeature | denotes | hereditary nephrotic syndrome |
| T7 | 173-180 | GeneOrGeneProduct | denotes | podocin |
| T8 | 191-196 | SequenceVariant | denotes | R138Q |
| T9 | 262-285 | DiseaseOrPhenotypicFeature | denotes | end-stage renal disease |
| T10 | 296-300 | OrganismTaxon | denotes | mice |
| T11 | 312-317 | SequenceVariant | denotes | R140Q |
| T12 | 332-337 | OrganismTaxon | denotes | mouse |
| T13 | 350-355 | OrganismTaxon | denotes | human |
| T14 | 356-361 | SequenceVariant | denotes | R138Q |
| T15 | 368-401 | DiseaseOrPhenotypicFeature | denotes | developmental arrest of podocytes |
| T16 | 413-426 | DiseaseOrPhenotypicFeature | denotes | renal failure |
| T17 | 474-481 | GeneOrGeneProduct | denotes | podocin |
| T18 | 503-508 | GeneOrGeneProduct | denotes | NPHS2 |
| T19 | 509-516 | SequenceVariant | denotes | R140Q/- |
| T20 | 526-535 | ChemicalEntity | denotes | tamoxifen |
| T21 | 546-561 | GeneOrGeneProduct | denotes | Cre recombinase |
| T22 | 658-663 | SequenceVariant | denotes | R140Q |
| T23 | 709-720 | DiseaseOrPhenotypicFeature | denotes | proteinuria |
| T24 | 799-812 | DiseaseOrPhenotypicFeature | denotes | renal failure |
| T25 | 871-890 | DiseaseOrPhenotypicFeature | denotes | Foot process fusion |
| T26 | 954-964 | DiseaseOrPhenotypicFeature | denotes | effacement |
| T27 | 1136-1167 | DiseaseOrPhenotypicFeature | denotes | segmentally sclerosed glomeruli |
| T28 | 1231-1258 | DiseaseOrPhenotypicFeature | denotes | tubulointerstitial fibrosis |
| T29 | 1346-1357 | DiseaseOrPhenotypicFeature | denotes | proteinuria |
| T30 | 1389-1394 | SequenceVariant | denotes | R140Q |
| T31 | 1395-1402 | GeneOrGeneProduct | denotes | podocin |
| T32 | 1525-1532 | GeneOrGeneProduct | denotes | miRNA21 |
| T33 | 1593-1603 | GeneOrGeneProduct | denotes | miRNA-193a |
| T34 | 1676-1681 | SequenceVariant | denotes | R140Q |
| T35 | 1682-1689 | GeneOrGeneProduct | denotes | podocin |
| T36 | 1690-1695 | OrganismTaxon | denotes | mouse |
| T37 | 1761-1766 | OrganismTaxon | denotes | human |
| T38 | 1767-1785 | DiseaseOrPhenotypicFeature | denotes | nephrotic syndrome |
| T39 | 1849-1854 | OrganismTaxon | denotes | human |
| T40 | 2027-2038 | DiseaseOrPhenotypicFeature | denotes | proteinuria |
| T41 | 2040-2058 | DiseaseOrPhenotypicFeature | denotes | glomerulosclerosis |
| T42 | 2075-2088 | DiseaseOrPhenotypicFeature | denotes | renal failure |
biored-valid-gemini-nr-g
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 13-18 | OrganismTaxon | denotes | mouse |
| T2 | 28-35 | GeneOrGeneProduct | denotes | podocin |
| T3 | 53-71 | DiseaseOrPhenotypicFeature | denotes | nephrotic syndrome |
| T4 | 90-95 | GeneOrGeneProduct | denotes | NPHS2 |
| T5 | 111-118 | GeneOrGeneProduct | denotes | podocin |
| T6 | 126-155 | DiseaseOrPhenotypicFeature | denotes | hereditary nephrotic syndrome |
| T7 | 173-180 | GeneOrGeneProduct | denotes | podocin |
| T8 | 181-189 | SequenceVariant | denotes | mutation |
| T9 | 191-196 | SequenceVariant | denotes | R138Q |
| T10 | 223-236 | DiseaseOrPhenotypicFeature | denotes | disease onset |
| T11 | 262-285 | DiseaseOrPhenotypicFeature | denotes | end-stage renal disease |
| T12 | 287-295 | GeneOrGeneProduct | denotes | Knock-in |
| T13 | 296-300 | OrganismTaxon | denotes | mice |
| T14 | 312-317 | SequenceVariant | denotes | R140Q |
| T15 | 318-326 | SequenceVariant | denotes | mutation |
| T16 | 332-337 | OrganismTaxon | denotes | mouse |
| T17 | 350-355 | OrganismTaxon | denotes | human |
| T18 | 356-361 | SequenceVariant | denotes | R138Q |
| T19 | 406-426 | DiseaseOrPhenotypicFeature | denotes | lethal renal failure |
| T20 | 474-481 | GeneOrGeneProduct | denotes | podocin |
| T21 | 482-490 | GeneOrGeneProduct | denotes | knock-in |
| T22 | 503-516 | SequenceVariant | denotes | NPHS2 R140Q/- |
| T23 | 526-535 | ChemicalEntity | denotes | tamoxifen |
| T24 | 546-561 | GeneOrGeneProduct | denotes | Cre recombinase |
| T25 | 605-613 | SequenceVariant | denotes | mutation |
| T26 | 658-663 | SequenceVariant | denotes | R140Q |
| T27 | 709-720 | DiseaseOrPhenotypicFeature | denotes | proteinuria |
| T28 | 787-812 | DiseaseOrPhenotypicFeature | denotes | progressive renal failure |
| T29 | 871-890 | DiseaseOrPhenotypicFeature | denotes | Foot process fusion |
| T30 | 936-964 | DiseaseOrPhenotypicFeature | denotes | severe and global effacement |
| T31 | 1136-1157 | DiseaseOrPhenotypicFeature | denotes | segmentally sclerosed |
| T32 | 1224-1258 | DiseaseOrPhenotypicFeature | denotes | Severe tubulointerstitial fibrosis |
| T33 | 1346-1357 | DiseaseOrPhenotypicFeature | denotes | proteinuria |
| T34 | 1389-1394 | SequenceVariant | denotes | R140Q |
| T35 | 1395-1402 | GeneOrGeneProduct | denotes | podocin |
| T36 | 1403-1407 | GeneOrGeneProduct | denotes | mRNA |
| T37 | 1525-1532 | GeneOrGeneProduct | denotes | miRNA21 |
| T38 | 1593-1603 | GeneOrGeneProduct | denotes | miRNA-193a |
| T39 | 1676-1681 | SequenceVariant | denotes | R140Q |
| T40 | 1682-1689 | GeneOrGeneProduct | denotes | podocin |
| T41 | 1690-1695 | OrganismTaxon | denotes | mouse |
| T42 | 1761-1766 | OrganismTaxon | denotes | human |
| T43 | 1767-1785 | DiseaseOrPhenotypicFeature | denotes | nephrotic syndrome |
| T44 | 2027-2038 | DiseaseOrPhenotypicFeature | denotes | proteinuria |
| T45 | 2040-2058 | DiseaseOrPhenotypicFeature | denotes | glomerulosclerosis |
| T46 | 2063-2088 | DiseaseOrPhenotypicFeature | denotes | progressive renal failure |
biored-valid-gpt-r-m
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 13-18 | OrganismTaxon | denotes | mouse |
| T2 | 28-35 | GeneOrGeneProduct | denotes | podocin |
| T3 | 53-71 | DiseaseOrPhenotypicFeature | denotes | nephrotic syndrome |
| T4 | 90-95 | GeneOrGeneProduct | denotes | NPHS2 |
| T5 | 111-118 | GeneOrGeneProduct | denotes | podocin |
| T6 | 137-155 | DiseaseOrPhenotypicFeature | denotes | nephrotic syndrome |
| T7 | 173-180 | GeneOrGeneProduct | denotes | podocin |
| T8 | 191-196 | SequenceVariant | denotes | R138Q |
| T9 | 262-285 | DiseaseOrPhenotypicFeature | denotes | end-stage renal disease |
| T10 | 296-300 | OrganismTaxon | denotes | mice |
| T11 | 312-317 | SequenceVariant | denotes | R140Q |
| T12 | 332-337 | OrganismTaxon | denotes | mouse |
| T13 | 350-355 | OrganismTaxon | denotes | human |
| T14 | 356-361 | SequenceVariant | denotes | R138Q |
| T15 | 413-426 | DiseaseOrPhenotypicFeature | denotes | renal failure |
| T16 | 474-481 | GeneOrGeneProduct | denotes | podocin |
| T17 | 503-508 | GeneOrGeneProduct | denotes | NPHS2 |
| T18 | 509-516 | SequenceVariant | denotes | R140Q/- |
| T19 | 526-535 | ChemicalEntity | denotes | tamoxifen |
| T20 | 546-561 | GeneOrGeneProduct | denotes | Cre recombinase |
| T21 | 658-663 | SequenceVariant | denotes | R140Q |
| T22 | 709-720 | DiseaseOrPhenotypicFeature | denotes | proteinuria |
| T23 | 799-812 | DiseaseOrPhenotypicFeature | denotes | renal failure |
| T24 | 871-890 | DiseaseOrPhenotypicFeature | denotes | Foot process fusion |
| T25 | 954-964 | DiseaseOrPhenotypicFeature | denotes | effacement |
| T26 | 1136-1167 | DiseaseOrPhenotypicFeature | denotes | segmentally sclerosed glomeruli |
| T27 | 1231-1258 | DiseaseOrPhenotypicFeature | denotes | tubulointerstitial fibrosis |
| T28 | 1346-1357 | DiseaseOrPhenotypicFeature | denotes | proteinuria |
| T29 | 1389-1394 | SequenceVariant | denotes | R140Q |
| T30 | 1395-1402 | GeneOrGeneProduct | denotes | podocin |
| T31 | 1525-1532 | GeneOrGeneProduct | denotes | miRNA21 |
| T32 | 1593-1603 | GeneOrGeneProduct | denotes | miRNA-193a |
| T33 | 1676-1681 | SequenceVariant | denotes | R140Q |
| T34 | 1682-1689 | GeneOrGeneProduct | denotes | podocin |
| T35 | 1690-1695 | OrganismTaxon | denotes | mouse |
| T36 | 1761-1766 | OrganismTaxon | denotes | human |
| T37 | 1767-1785 | DiseaseOrPhenotypicFeature | denotes | nephrotic syndrome |
| T38 | 1849-1854 | OrganismTaxon | denotes | human |
| T39 | 2027-2038 | DiseaseOrPhenotypicFeature | denotes | proteinuria |
| T40 | 2040-2058 | DiseaseOrPhenotypicFeature | denotes | glomerulosclerosis |
| T41 | 2075-2088 | DiseaseOrPhenotypicFeature | denotes | renal failure |
biored-valid-gemini-r-m
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 13-18 | OrganismTaxon | denotes | mouse |
| T2 | 28-35 | GeneOrGeneProduct | denotes | podocin |
| T3 | 53-71 | DiseaseOrPhenotypicFeature | denotes | nephrotic syndrome |
| T4 | 90-95 | GeneOrGeneProduct | denotes | NPHS2 |
| T5 | 111-118 | GeneOrGeneProduct | denotes | podocin |
| T6 | 126-155 | DiseaseOrPhenotypicFeature | denotes | hereditary nephrotic syndrome |
| T7 | 173-180 | GeneOrGeneProduct | denotes | podocin |
| T8 | 191-196 | SequenceVariant | denotes | R138Q |
| T9 | 262-285 | DiseaseOrPhenotypicFeature | denotes | end-stage renal disease |
| T10 | 296-300 | OrganismTaxon | denotes | mice |
| T11 | 312-317 | SequenceVariant | denotes | R140Q |
| T12 | 332-337 | OrganismTaxon | denotes | mouse |
| T13 | 350-355 | OrganismTaxon | denotes | human |
| T14 | 356-361 | SequenceVariant | denotes | R138Q |
| T15 | 368-388 | DiseaseOrPhenotypicFeature | denotes | developmental arrest |
| T16 | 406-426 | DiseaseOrPhenotypicFeature | denotes | lethal renal failure |
| T17 | 474-481 | GeneOrGeneProduct | denotes | podocin |
| T18 | 503-508 | GeneOrGeneProduct | denotes | NPHS2 |
| T19 | 509-514 | SequenceVariant | denotes | R140Q |
| T20 | 526-535 | ChemicalEntity | denotes | tamoxifen |
| T21 | 546-561 | GeneOrGeneProduct | denotes | Cre recombinase |
| T22 | 658-663 | SequenceVariant | denotes | R140Q |
| T23 | 691-698 | OrganismTaxon | denotes | animals |
| T24 | 709-720 | DiseaseOrPhenotypicFeature | denotes | proteinuria |
| T25 | 787-812 | DiseaseOrPhenotypicFeature | denotes | progressive renal failure |
| T26 | 871-890 | DiseaseOrPhenotypicFeature | denotes | Foot process fusion |
| T27 | 954-964 | DiseaseOrPhenotypicFeature | denotes | effacement |
| T28 | 1082-1090 | OrganismTaxon | denotes | controls |
| T29 | 1136-1167 | DiseaseOrPhenotypicFeature | denotes | segmentally sclerosed glomeruli |
| T30 | 1231-1258 | DiseaseOrPhenotypicFeature | denotes | tubulointerstitial fibrosis |
| T31 | 1346-1357 | DiseaseOrPhenotypicFeature | denotes | proteinuria |
| T32 | 1389-1394 | SequenceVariant | denotes | R140Q |
| T33 | 1395-1407 | GeneOrGeneProduct | denotes | podocin mRNA |
| T34 | 1525-1532 | GeneOrGeneProduct | denotes | miRNA21 |
| T35 | 1593-1603 | GeneOrGeneProduct | denotes | miRNA-193a |
| T36 | 1690-1695 | OrganismTaxon | denotes | mouse |
| T37 | 1761-1766 | OrganismTaxon | denotes | human |
| T38 | 1767-1785 | DiseaseOrPhenotypicFeature | denotes | nephrotic syndrome |
| T39 | 2027-2038 | DiseaseOrPhenotypicFeature | denotes | proteinuria |
| T40 | 2040-2058 | DiseaseOrPhenotypicFeature | denotes | glomerulosclerosis |
| T41 | 2063-2088 | DiseaseOrPhenotypicFeature | denotes | progressive renal failure |
biored-valid-deepseek-r-m
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 13-18 | OrganismTaxon | denotes | mouse |
| T2 | 28-35 | GeneOrGeneProduct | denotes | podocin |
| T3 | 53-71 | DiseaseOrPhenotypicFeature | denotes | nephrotic syndrome |
| T4 | 90-95 | GeneOrGeneProduct | denotes | NPHS2 |
| T5 | 111-118 | GeneOrGeneProduct | denotes | podocin |
| T6 | 191-196 | SequenceVariant | denotes | R138Q |
| T7 | 262-285 | DiseaseOrPhenotypicFeature | denotes | end-stage renal disease |
| T8 | 296-300 | OrganismTaxon | denotes | mice |
| T9 | 312-317 | SequenceVariant | denotes | R140Q |
| T10 | 332-337 | OrganismTaxon | denotes | mouse |
| T11 | 350-355 | OrganismTaxon | denotes | human |
| T12 | 368-388 | DiseaseOrPhenotypicFeature | denotes | developmental arrest |
| T13 | 413-426 | DiseaseOrPhenotypicFeature | denotes | renal failure |
| T14 | 474-481 | GeneOrGeneProduct | denotes | podocin |
| T15 | 503-508 | GeneOrGeneProduct | denotes | NPHS2 |
| T16 | 509-514 | SequenceVariant | denotes | R140Q |
| T17 | 526-535 | ChemicalEntity | denotes | tamoxifen |
| T18 | 546-561 | GeneOrGeneProduct | denotes | Cre recombinase |
| T19 | 658-663 | SequenceVariant | denotes | R140Q |
| T20 | 709-720 | DiseaseOrPhenotypicFeature | denotes | proteinuria |
| T21 | 799-812 | DiseaseOrPhenotypicFeature | denotes | renal failure |
| T22 | 1136-1167 | DiseaseOrPhenotypicFeature | denotes | segmentally sclerosed glomeruli |
| T23 | 1231-1258 | DiseaseOrPhenotypicFeature | denotes | tubulointerstitial fibrosis |
| T24 | 1346-1357 | DiseaseOrPhenotypicFeature | denotes | proteinuria |
| T25 | 1525-1532 | GeneOrGeneProduct | denotes | miRNA21 |
| T26 | 1593-1603 | GeneOrGeneProduct | denotes | miRNA-193a |
| T27 | 1761-1766 | OrganismTaxon | denotes | human |
| T28 | 1767-1785 | DiseaseOrPhenotypicFeature | denotes | nephrotic syndrome |
| T29 | 2040-2058 | DiseaseOrPhenotypicFeature | denotes | glomerulosclerosis |